应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MEIP MEI Pharma
盘后交易 05-21 18:07:53 EDT
3.12
+0.01
+0.32%
盘后
3.15
+0.03
+0.96%
17:32 EDT
最高
3.16
最低
3.11
成交量
4,978
今开
3.16
昨收
3.11
日振幅
1.61%
总市值
2,079万
流通市值
1,542万
总股本
666.29万
成交额
1.55万
换手率
0.10%
流通股本
494.13万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Mei Pharma, Inc.盘中异动 股价大跌5.00%
自选股智能写手 · 05-07
Mei Pharma, Inc.盘中异动 股价大跌5.00%
MEI Pharma Inc 预计每股亏损 1.52 美元 - 财报前瞻
Reuters · 05-07
MEI Pharma Inc 预计每股亏损 1.52 美元 - 财报前瞻
Mei Pharma, Inc.盘中异动 早盘快速拉升7.84%
自选股智能写手 · 05-06
Mei Pharma, Inc.盘中异动 早盘快速拉升7.84%
Mei Pharma, Inc.盘中异动 快速上涨7.50%
自选股智能写手 · 04-17
Mei Pharma, Inc.盘中异动 快速上涨7.50%
Mei Pharma, Inc.盘中异动 早盘大幅拉升5.95%
自选股智能写手 · 04-16
Mei Pharma, Inc.盘中异动 早盘大幅拉升5.95%
Stifel:维持MEI Pharma(MEIP.US)评级,由持有调整至持有评级, 目标价由7.00美元调整至7.00美元。
智通财经 · 04-12
Stifel:维持MEI Pharma(MEIP.US)评级,由持有调整至持有评级, 目标价由7.00美元调整至7.00美元。
Mei Pharma, Inc.盘中异动 大幅下跌5.23%
自选股智能写手 · 04-12
Mei Pharma, Inc.盘中异动 大幅下跌5.23%
Mei Pharma, Inc.盘中异动 临近收盘大幅跳水5.06%
自选股智能写手 · 04-06
Mei Pharma, Inc.盘中异动 临近收盘大幅跳水5.06%
Mei Pharma, Inc.盘中异动 临近收盘大幅上涨5.81%报4.11美元
自选股智能写手 · 04-03
Mei Pharma, Inc.盘中异动 临近收盘大幅上涨5.81%报4.11美元
Mei Pharma, Inc.盘中异动 股价大跌7.54%报3.58美元
自选股智能写手 · 03-26
Mei Pharma, Inc.盘中异动 股价大跌7.54%报3.58美元
Mei Pharma, Inc.盘中异动 下午盘股价大涨5.23%
自选股智能写手 · 03-23
Mei Pharma, Inc.盘中异动 下午盘股价大涨5.23%
Mei Pharma, Inc.盘中异动 快速上涨6.15%报3.80美元
自选股智能写手 · 03-21
Mei Pharma, Inc.盘中异动 快速上涨6.15%报3.80美元
Mei Pharma, Inc.盘中异动 股价大涨5.11%报3.91美元
自选股智能写手 · 03-20
Mei Pharma, Inc.盘中异动 股价大涨5.11%报3.91美元
Mei Pharma, Inc.盘中异动 早盘股价大跌5.21%报3.63美元
自选股智能写手 · 03-18
Mei Pharma, Inc.盘中异动 早盘股价大跌5.21%报3.63美元
Mei Pharma, Inc.盘中异动 股价大跌5.48%报3.86美元
自选股智能写手 · 03-15
Mei Pharma, Inc.盘中异动 股价大跌5.48%报3.86美元
Mei Pharma, Inc.盘中异动 股价大涨5.00%报3.99美元
自选股智能写手 · 03-11
Mei Pharma, Inc.盘中异动 股价大涨5.00%报3.99美元
Mei Pharma, Inc.盘中异动 下午盘股价大涨7.49%报3.81美元
自选股智能写手 · 03-09
Mei Pharma, Inc.盘中异动 下午盘股价大涨7.49%报3.81美元
Mei Pharma, Inc.盘中异动 股价大跌5.28%报3.77美元
自选股智能写手 · 03-06
Mei Pharma, Inc.盘中异动 股价大跌5.28%报3.77美元
Mei Pharma, Inc.盘中异动 下午盘股价大跌5.01%报4.03美元
自选股智能写手 · 03-06
Mei Pharma, Inc.盘中异动 下午盘股价大跌5.01%报4.03美元
Mei Pharma Inc盘中异动 临近收盘快速下挫5.29%
自选股智能写手 · 02-23
Mei Pharma Inc盘中异动 临近收盘快速下挫5.29%
加载更多
公司概况
公司名称:
MEI Pharma
所属市场:
NASDAQ
上市日期:
--
主营业务:
MEI Pharma, Inc.是一家临床阶段的制药公司,致力于开发新型和差异化的癌症疗法。该公司通过收购有前途的癌症药物来建立管道,并通过临床开发、战略合作伙伴关系以及外包许可或商业化(视情况而定)在项目中创造价值。候选药物包括口服细胞周期蛋白依赖性激酶9抑制剂voruciclib和靶向氧化磷酸化途径的静脉注射小分子线粒体抑制剂ME-344。
发行价格:
--
{"stockData":{"symbol":"MEIP","market":"US","secType":"STK","nameCN":"MEI Pharma","latestPrice":3.12,"timestamp":1716321600000,"preClose":3.11,"halted":0,"volume":4978,"hourTrading":{"tag":"盘后","latestPrice":3.15,"preClose":3.12,"latestTime":"17:32 EDT","volume":291,"amount":914.8140228,"timestamp":1716327155606},"delay":0,"floatShares":4941323,"shares":6662857,"eps":3.925408,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.01,"latestTime":"05-21 18:07:53 EDT","open":3.16,"high":3.16,"low":3.11,"amount":15547.3533184,"amplitude":0.016077,"askPrice":3.25,"askSize":2050,"bidPrice":3.09,"bidSize":200,"shortable":3,"etf":0,"ttmEps":3.925408,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1716336000000},"adr":0,"listingDate":1071723600000,"adjPreClose":3.11,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":3.21,"preClose":3.11,"latestTime":"09:06 EDT","volume":107,"amount":343.46999999999997,"timestamp":1716296782581},"postHourTrading":{"tag":"盘后","latestPrice":3.15,"preClose":3.12,"latestTime":"17:32 EDT","volume":291,"amount":914.8140228,"timestamp":1716327155606},"volumeRatio":0.196915},"requestUrl":"/m/hq/s/MEIP","defaultTab":"news","newsList":[{"id":"2433786493","title":"Mei Pharma, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433786493","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433786493?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:32","pubTimestamp":1715092327,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日22时32分,Mei Pharma, Inc.股票出现波动,股价大幅下挫5.00%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.76%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072232077a58871f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072232077a58871f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433274031","title":"MEI Pharma Inc 预计每股亏损 1.52 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433274031","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433274031?lang=zh_cn&edition=full","pubTime":"2024-05-07 19:24","pubTimestamp":1715081049,"startTime":"0","endTime":"0","summary":" * MEI Pharma Inc 预计将在5月9日公布截至2024年3月31日的业绩报告时显示季度收入下降(预计) * 根据LSEG的数据,2位分析师的平均预期显示,这家总部位于加利福尼亚州圣地亚哥的公司的营收预计将从去年同期的589万美元下降99.4%,至3.75万美元。* LSEG的分析师平均预计MEI Pharma Inc每股亏损1.52美元。* 华尔街对 MEI Pharma Inc 的 12 个月目标价中位数为 20.00 美元,高于其上次收盘价 3.20 美元。5月7日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433479745","title":"Mei Pharma, Inc.盘中异动 早盘快速拉升7.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433479745","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433479745?lang=zh_cn&edition=full","pubTime":"2024-05-06 21:38","pubTimestamp":1715002717,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日21时38分,Mei Pharma, Inc.股票出现异动,股价大幅上涨7.84%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.32%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506213837861eb2f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506213837861eb2f1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428734725","title":"Mei Pharma, Inc.盘中异动 快速上涨7.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428734725","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428734725?lang=zh_cn&edition=full","pubTime":"2024-04-17 23:13","pubTimestamp":1713366783,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日23时13分,Mei Pharma, Inc.股票出现异动,股价快速上涨7.50%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.66%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Vanda Pharmaceuticals Inc.、Galera Therapeutics, Inc.涨幅较大,Palisade Bio, Inc.、Longeveron Inc.、Jaguar Health, Inc.较为活跃,换手率分别为138.45%、38.18%、37.71%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Dare Bioscience, Inc.,振幅分别为80.94%、50.74%、41.02%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041723130387e81689&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041723130387e81689&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427788258","title":"Mei Pharma, Inc.盘中异动 早盘大幅拉升5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427788258","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427788258?lang=zh_cn&edition=full","pubTime":"2024-04-16 21:30","pubTimestamp":1713274247,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日21时30分,Mei Pharma, Inc.股票出现异动,股价大幅上涨5.95%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162130487a532d0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162130487a532d0e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427732989","title":"Stifel:维持MEI Pharma(MEIP.US)评级,由持有调整至持有评级, 目标价由7.00美元调整至7.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2427732989","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427732989?lang=zh_cn&edition=full","pubTime":"2024-04-12 23:54","pubTimestamp":1712937280,"startTime":"0","endTime":"0","summary":"Stifel:维持MEI Pharma(MEIP.US)评级,由持有调整至持有评级, 目标价由7.00美元调整至7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412235442876ffb2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412235442876ffb2f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426735355","title":"Mei Pharma, Inc.盘中异动 大幅下跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426735355","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426735355?lang=zh_cn&edition=full","pubTime":"2024-04-12 22:02","pubTimestamp":1712930530,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日22时02分,Mei Pharma, Inc.股票出现异动,股价快速下跌5.23%。Mei Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.46%。其相关个股中,Paxmedica, Inc.、Allarity Therapeutics, Inc.、Q32 Bio Inc.涨幅较大,Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃,换手率分别为2653.58%、918.80%、51.87%,振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025,振幅分别为69.81%、60.95%、58.59%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041222021087e7ff53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041222021087e7ff53&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425951684","title":"Mei Pharma, Inc.盘中异动 临近收盘大幅跳水5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425951684","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425951684?lang=zh_cn&edition=full","pubTime":"2024-04-06 03:59","pubTimestamp":1712347144,"startTime":"0","endTime":"0","summary":"北京时间2024年04月06日03时59分,Mei Pharma, Inc.股票出现波动,股价快速跳水5.06%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.93%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240406035904791edc90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240406035904791edc90&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424729690","title":"Mei Pharma, Inc.盘中异动 临近收盘大幅上涨5.81%报4.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424729690","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424729690?lang=zh_cn&edition=full","pubTime":"2024-04-03 03:51","pubTimestamp":1712087464,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日03时51分,Mei Pharma, Inc.股票出现异动,股价大幅上涨5.81%。Mei Pharma, Inc.股票所在的生物技术行业中,整体跌幅为1.51%。其相关个股中,180 Life Sciences Corp C/Wts 07/11/2025、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Q32 Bio Inc.涨幅较大,Aditxt, Inc.、Processa Pharmaceuticals, Inc.、Gamida Cell Ltd.较为活跃,换手率分别为946.31%、170.91%、71.39%,振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Aditxt, Inc.、180 Life Sciences Corp C/Wts 07/11/2025,振幅分别为125.82%、67.61%、67.07%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403035104861e3135&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403035104861e3135&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422615520","title":"Mei Pharma, Inc.盘中异动 股价大跌7.54%报3.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422615520","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422615520?lang=zh_cn&edition=full","pubTime":"2024-03-26 21:34","pubTimestamp":1711460043,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日21时34分,Mei Pharma, Inc.股票出现异动,股价大幅下跌7.54%。截至发稿,该股报3.58美元/股,成交量3486股,换手率0.05%,振幅2.76%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.37%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326213403861e13ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326213403861e13ec&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421821600","title":"Mei Pharma, Inc.盘中异动 下午盘股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421821600","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421821600?lang=zh_cn&edition=full","pubTime":"2024-03-23 03:19","pubTimestamp":1711135157,"startTime":"0","endTime":"0","summary":"北京时间2024年03月23日03时19分,Mei Pharma, Inc.股票出现异动,股价急速上涨5.23%。Mei Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.13%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032303191787e7b1e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032303191787e7b1e9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421042067","title":"Mei Pharma, Inc.盘中异动 快速上涨6.15%报3.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421042067","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421042067?lang=zh_cn&edition=full","pubTime":"2024-03-21 22:44","pubTimestamp":1711032261,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日22时44分,Mei Pharma, Inc.股票出现异动,股价快速拉升6.15%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.68%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032122442187e7abe4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032122442187e7abe4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420272448","title":"Mei Pharma, Inc.盘中异动 股价大涨5.11%报3.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420272448","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420272448?lang=zh_cn&edition=full","pubTime":"2024-03-20 00:10","pubTimestamp":1710864647,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日00时10分,Mei Pharma, Inc.股票出现波动,股价大幅上涨5.11%。截至发稿,该股报3.91美元/股,成交量2170股,换手率0.03%,振幅3.49%。Mei Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.29%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032000104787e7a1c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032000104787e7a1c8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420472387","title":"Mei Pharma, Inc.盘中异动 早盘股价大跌5.21%报3.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420472387","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420472387?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:45","pubTimestamp":1710769502,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时45分,Mei Pharma, Inc.股票出现波动,股价大幅下跌5.21%。截至发稿,该股报3.63美元/股,成交量903股,换手率0.01%,振幅0.00%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318214502861df1b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318214502861df1b9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419982113","title":"Mei Pharma, Inc.盘中异动 股价大跌5.48%报3.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419982113","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419982113?lang=zh_cn&edition=full","pubTime":"2024-03-15 00:11","pubTimestamp":1710432694,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日00时11分,Mei Pharma, Inc.股票出现异动,股价急速下跌5.48%。截至发稿,该股报3.86美元/股,成交量9642股,换手率0.14%,振幅7.60%。Mei Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.32%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031500113587e78fc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031500113587e78fc3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418501953","title":"Mei Pharma, Inc.盘中异动 股价大涨5.00%报3.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418501953","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418501953?lang=zh_cn&edition=full","pubTime":"2024-03-11 21:37","pubTimestamp":1710164250,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日21时37分,Mei Pharma, Inc.股票出现波动,股价大幅上涨5.00%。截至发稿,该股报3.99美元/股,成交量4668股,换手率0.07%,振幅3.68%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.52%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311213730861dd137&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311213730861dd137&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418093017","title":"Mei Pharma, Inc.盘中异动 下午盘股价大涨7.49%报3.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418093017","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418093017?lang=zh_cn&edition=full","pubTime":"2024-03-09 02:30","pubTimestamp":1709922606,"startTime":"0","endTime":"0","summary":"北京时间2024年03月09日02时30分,Mei Pharma, Inc.股票出现波动,股价大幅上涨7.49%。截至发稿,该股报3.81美元/股,成交量3.1493万股,换手率0.47%,振幅6.49%。Mei Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.87%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403090230077a4ae808&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403090230077a4ae808&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417075218","title":"Mei Pharma, Inc.盘中异动 股价大跌5.28%报3.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417075218","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417075218?lang=zh_cn&edition=full","pubTime":"2024-03-06 23:18","pubTimestamp":1709738282,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日23时18分,Mei Pharma, Inc.股票出现异动,股价急速跳水5.28%。截至发稿,该股报3.77美元/股,成交量1.4118万股,换手率0.21%,振幅6.03%。Mei Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.22%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403062318037a4a2000&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403062318037a4a2000&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417423766","title":"Mei Pharma, Inc.盘中异动 下午盘股价大跌5.01%报4.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417423766","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417423766?lang=zh_cn&edition=full","pubTime":"2024-03-06 02:57","pubTimestamp":1709665026,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日02时57分,Mei Pharma, Inc.股票出现波动,股价大幅下挫5.01%。截至发稿,该股报4.03美元/股,成交量2.292万股,换手率0.34%,振幅5.17%。Mei Pharma, Inc.股票所在的生物技术行业中,整体跌幅为1.59%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030602570779178c3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030602570779178c3d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413229929","title":"Mei Pharma Inc盘中异动 临近收盘快速下挫5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413229929","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413229929?lang=zh_cn&edition=full","pubTime":"2024-02-23 04:55","pubTimestamp":1708635323,"startTime":"0","endTime":"0","summary":"北京时间2024年02月23日04时55分,Mei Pharma Inc股票出现异动,股价急速下挫5.29%。Mei Pharma Inc股票所在的生物技术行业中,整体涨幅为2.02%。Mei Pharma Inc公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402230455247a45ca80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402230455247a45ca80&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.meipharma.com","stockEarnings":[{"period":"1week","weight":-0.0032},{"period":"1month","weight":-0.0431},{"period":"3month","weight":-0.3058},{"period":"6month","weight":-0.4968},{"period":"1year","weight":-0.5913},{"period":"ytd","weight":-0.4638}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.0705},{"period":"3month","weight":0.067},{"period":"6month","weight":0.1649},{"period":"1year","weight":0.2662},{"period":"ytd","weight":0.1152}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MEI Pharma, Inc.是一家临床阶段的制药公司,致力于开发新型和差异化的癌症疗法。该公司通过收购有前途的癌症药物来建立管道,并通过临床开发、战略合作伙伴关系以及外包许可或商业化(视情况而定)在项目中创造价值。候选药物包括口服细胞周期蛋白依赖性激酶9抑制剂voruciclib和靶向氧化磷酸化途径的静脉注射小分子线粒体抑制剂ME-344。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.057007},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.001286},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.071045},{"month":4,"riseRate":0.571429,"avgChangeRate":0.02424},{"month":5,"riseRate":0.47619,"avgChangeRate":0.040361},{"month":6,"riseRate":0.3,"avgChangeRate":-0.097246},{"month":7,"riseRate":0.3,"avgChangeRate":0.016603},{"month":8,"riseRate":0.421053,"avgChangeRate":-0.000433},{"month":9,"riseRate":0.578947,"avgChangeRate":0.085484},{"month":10,"riseRate":0.368421,"avgChangeRate":-0.068122},{"month":11,"riseRate":0.473684,"avgChangeRate":-0.034317},{"month":12,"riseRate":0.25,"avgChangeRate":0.024923}],"exchange":"NASDAQ","name":"MEI Pharma","nameEN":"MEI Pharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MEI Pharma(MEIP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MEI Pharma(MEIP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MEI Pharma,MEIP,MEI Pharma股票,MEI Pharma股票老虎,MEI Pharma股票老虎国际,MEI Pharma行情,MEI Pharma股票行情,MEI Pharma股价,MEI Pharma股市,MEI Pharma股票价格,MEI Pharma股票交易,MEI Pharma股票购买,MEI Pharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MEI Pharma(MEIP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MEI Pharma(MEIP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}